Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
They charge more in wealthy countries and less in developing economies
Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
Meet our doctors Last reviewed: 19 Jun 2026 Sources Mounjaro KwikPen 10mg solution for injection in pre-filled pen SmPC, emc [accessed 25 May 2026] Once-Weekly Semaglutide in Adults with Overweight or Obesity, The New England Journal of Medicine (NEJM) [accessed 25 May 2026] Ozempic SmPC, emc [accessed 25 May 2026] Rybelsus 3 mg, emc [accessed 25 May 2026] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, NEJM [accessed 25 May 2026]
Mounjaro is not generally covered for weight loss since its not FDA approved for weight loss
doi: 10.1096/fasebj.8.15.8001743
US$ 25.70
US$ 20.13
US$ 29.82
